TuHURA Biosciences, Inc.
NASDAQ:HURA · NASDAQ Capital Market
+$0.14 today
Vol 1.08M · Avg 0.85M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+1.58%
Period High
$3.25
Period Low
$0.44
Latest
$2.57
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$335.63M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.80M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$126.51M
Agenus Inc.
NASDAQ:AGEN
$123.47M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$104.58M
Seer, Inc.
NASDAQ:SEER
$94.29M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$61.88M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.15M
Tevogen Bio Holdings Inc.
TVGN
$43.63M
VistaGen Therapeutics, Inc.
VTGN
$22.73M
What is the latest HURA filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does HURA have?
Intrinsic Alpha currently shows 20 recent filings for HURA.
Explore More
Continue the stock analysis
Jump to another research area for this company.